Merck and Singapore signal deal on COVID-19 antiviral tablet

An experimental COVID-19 remedy tablet known as molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen on this undated handout photograph launched by Merck & Co Inc and obtained by Reuters Might 17, 2021. Merck & Co Inc/Handout through REUTERS

SINGAPORE, Oct 6 (Reuters) – Pharmaceutical firm Merck (MRK.N) introduced on Wednesday a provide and buy settlement with Singapore that may guarantee it entry to its experimental oral COVID-19 antiviral drug, the newest Asian nation aiming to get provides.

The drug Molnupiravir is designed to introduce errors into the genetic code of the coronavirus and can be the primary oral antiviral medicine for COVID-19. Merck is in search of approval from the U.S. Meals and Drug Administration for the tablet.

Singapore’s well being ministry confirmed the deal although it declined to touch upon the variety of doses it bought, citing industrial sensitivities.

The ministry mentioned molnupiravir can be obtainable to be used after Merck, also referred to as MSD Pharma in Singapore, submitted information to the Well being Sciences Authority (HSA) and will get authorisation to be used in Singapore.

“The addition of molnupiravir to our portfolio of COVID-19 therapeutics ensures that we have now a spread of remedy choices for various affected person teams,” the ministry advised Reuters in an e-mail.

There isn’t any molnupiravir scientific trial in Singapore, it added.

Australia has additionally purchased the Merck tablet, whereas Thailand, South Korea, Taiwan and Malaysia have been in talks to purchase it. The Philippines hopes its trial of the tablet would permit it entry.

The push to order the drug comes after information from interim scientific trials launched on Friday indicated it might scale back by about 50% the probability of hospitalisation or dying for sufferers liable to extreme COVID-19.

Singapore reported a document 3,486 new coronavirus circumstances on Tuesday because it offers with its largest outbreak of the pandemic.

It has vaccinated 83% of its folks in opposition to COVID-19.

Reporting by Chen Lin; Enhancing by Martin Petty, Robert Birsel

Our Requirements: The Thomson Reuters Belief Rules.

Previous post SCORE searching for former enterprise execs to mentor, educate entrepreneurs
Next post Overture Middle gifted two $100k donations from resident, native enterprise